Ogryzko VV, Brinkmann E, Howard BH, Pastan I, Brinkmann U: Antisense inhibition of CAS, the human homologue of the yeast chromosome segregation gene CSE1, interferes with

mitosis in HeLa cells. Biochemistry 1997, 36:9493–9500.PubMedCrossRef 54. Brinkmann U: CAS, the human homologue of the yeast chromosome-segregation gene CSE1, in proliferation, apoptosis, and cancer. Am J Hum Genet 1998, 62:509–513.PubMedCrossRef 55. Jiang MC, Liao CF: CSE1/CAS overexpression inhibits the tumorigenicity of HT-29 colon cancer cells. J Exp Clin Cancer Res 2004, 23:325–332.PubMed 56. Le Bivic A, Hirn M, Reggio H: HT-29 cells are an in vitro model for the generation of cell polarity in Selleckchem AR-13324 epithelia during embryonic differentiation. Proc Natl Acad Sci USA 1988, 85:136–140.PubMedCrossRef 57. Wodarz A: Tumor suppressors: linking cell polarity and growth control. Curr Biol 2000, 10:624–626.CrossRef 58. Jiang MC, Liao CF, Tai CC: CAS/CSE 1 stimulates E-cadhrin-dependent cell polarity in HT-29 human colon epithelial cells. Biochem Biophys Res Commun 2002, 294:900–905.PubMedCrossRef 59. Moeller SJ, Sheaff RJ: G1 phase: components, conundrums, context. Results Probl Cell Differ 2006, 42:1–29.PubMedCrossRef 60. Giono LE, Manfredi JJ: The p53 tumor suppressor participates in multiple

eFT508 datasheet cell cycle checkpoints. J Cell Physiol 2006, 209:13–20.PubMedCrossRef 61. Boehme KA, Blattner C: Regulation of p53-insights into a complex process. Crit Rev Biochem Mol Biol 2009, 44:367–392.PubMedCrossRef 62. Kutay U, Bischoff FR, Kostka S, Kraft R, Görlich D: Export

of importin alpha from the nucleus is mediated by a specific nuclear transport factor. Cell 1997, 90:1061–1071.PubMedCrossRef Adenylyl cyclase 63. Tung MC, Tsai CS, Tung JN, Tsao TY, Chen HC, Yeh KT, Liao CF, Jiang MC: Higher prevalence of secretory CSE1L/CAS in sera of patients with metastatic cancer. Cancer Epidemiol Biomarkers Prev 2009, 18:1570–1577.PubMedCrossRef 64. Pickett JA, Edwardson JM: Compound exocytosis: mechanisms and functional significance. Traffic 2006, 7:109–116.PubMedCrossRef 65. Ayala I, Baldassarre M, Caldieri G, Buccione R: Invadopodia: a guided tour. Eur J Cell Biol 2006, 85:159–164.PubMedCrossRef 66. Tsao TY, Tsai CS, Tung JN, Chen SL, Yue CH, Liao CF, Wang CC, Jiang MC: Function of CSE1L/CAS in the Capmatinib chemical structure secretion of HT-29 human colorectal cells and its expression in human colon. Mol Cell Biochem 2009, 327:163–170.PubMedCrossRef 67. DeClerck YA, Mercurio AM, Stack MS, Chapman HA, Zutter MM, Muschel RJ, Raz A, Matrisian LM, Sloane BF, Noel A, Hendrix MJ, Coussens L, Padarathsingh M: Proteases, extracellular matrix, and cancer: a workshop of the path B study section. Am J Pathol 2004, 164:1131–1139.PubMedCrossRef 68. Tsanou E, Ioachim E, Briasoulis E, Charchanti A, Damala K, Karavasilis V, Pavlidis N, Agnantis NJ: Clinicopathological study of the expression of syndecan-1 in invasive breast carcinomas. correlation with extracellular matrix components. J Exp Clin Cancer Res 2004, 23:641–650.PubMed 69.